Introduction
Heart failure is a common complication in the dialysis population. Harnett et al. reported that nearly one-third of the dialysis patients had heart failure at initiation of dialysis. Of these, over half developed recurrences while on dialysis. Even among patients with no baseline heart failure, 25% developed heart failure subsequently during the course of dialysis [1] . The presence of heart failure at baseline predicts an increased mortality, both in the short term [2] and long term [1] , and is often complicated by cachexia that is common in these patients. In the general non-renal failure population, the frequency of body wasting has been reported to be ∼12-16% [3, 4] , but can be up to 50% in those with severe heart failure [5] . Our recent finding suggested that 59% of chronic peritoneal dialysis (PD) patients with previous circulatory congestion were malnourished, and this prevalence was significantly higher compared to those without (36%; P < 0.001) [6] . However, it is currently not known whether body muscle wasting may in turn predict an increased risk of circulatory congestion in the dialysis population including patients receiving PD and which nutritional parameter may best predict risk of circulatory congestion.
Handgrip muscle strength (HGS) is a simple, easily performed bedside test. It is a useful marker of nutritional status in both haemodialysis [7] and PD patients [8] . It reflects body lean muscle mass [9] and predicts survival in end-stage renal disease (ESRD) [8] . Studies in other non-renal failure population groups reported a similar association between a low HGS and poor nutrition status [10, 11] . There is also recent evidence that HGS may be a useful marker of frailty, being a powerful predictor of disability, morbidity and mortality [12] .
Given this background, we aimed to test the hypothesis that a low HGS may reflect a diseased cardiac status and predict future risk of circulatory congestion in chronic PD patients.
Materials and methods
We performed a prospective cohort study with a 4-year follow-up in a single regional dialysis centre in Hong Kong. The study protocol was approved by the Human Clinical Research Ethics Committee of the Chinese University of Hong Kong. Informed consent was obtained from all study participants.
Patients
Patients eligible for study inclusion were those with ESRD who have been maintained on continuous PD treatment for ≥3 months. We excluded patients with underlying active malignancy, active systemic lupus erythematosus, chronic rheumatic heart disease and congenital heart disease, and patients with incomplete data. Altogether, 218 chronic PD patients were recruited based on the study inclusion and exclusion criteria, representing 80.7% of the PD population in the centre. All patients were dialysed using conventional lactate-buffered glucose-based PD solutions.
Collection of clinical data
Patients'demographics and clinical data were obtained at study entry. Background atherosclerotic vascular disease (AVD) was defined as the presence of coronary artery disease (indicated by history of angina, previous myocardial infarction with or without history of coronary artery bypass surgery, or percutaneous coronary intervention), cerebrovascular disease (indicated by history of cerebrovascular event) or peripheral vascular disease (indicated by the presence of intermittent claudication or resting leg pain, together with clinical signs of peripheral vascular disease with or without history of amputation or revascularization).
Assessment of HGS and other nutrition parameters
At study entry, HGS was assessed in all patients using the Smedley handy dynamometer. Patients were instructed to apply as much handgrip pressure as possible, using the non-dominant hand. The measurements were repeated three times, and the highest score was recorded in kilograms. The coefficient of variation of HGS measurement was 4.86% for the right hand and 4.85% for the left hand in men and 5.84% for the right hand and 6.60% for the left hand in women, and was estimated by doing HGS measurement in both hands on two separate occasions, 1 week apart in 1998 men and 1996 women. Subjective global assessment (SGA) was performed by experienced research staff blinded to all clinical and biochemical parameters of patients. SGA includes six subjective assessments, three based on the patient history of weight loss, presence of anorexia and vomiting, and three based on the physician grading of muscle wasting, presence of oedema and loss of subcutaneous fat [13, 14] . Oedema is not a useful index of malnutrition [14] , but its presence or absence has to be taken into account when assessing changes in body weight. Based on these assessments, each patient was graded a score that reflected the nutrition status, namely 1 = normal nutrition, 2 = mild malnutrition, and 3 = moderate and severe malnutrition.
Biochemical parameters
Ten-millilitre fasting venous blood samples were collected at study entry for measurement of blood haemoglobin (STKS Counter, Beckman-Coulter Inc, Miami, FL, USA), serum albumin (bromcresol purple method), urea and creatinine (D & P Modular Analyser, Roche Diagnostics GmbH, Mannheim, Germany), high-sensitivity C-reactive protein (hs-CRP; IMMULITE Analyzer, Siemens Healthcare Diagnostics, Deerfield, IL, USA), total cholesterol and triglyceride (Hitachi 911 analyser, Roche Diagnostics GmbH, Mannheim, Germany), intact parathyroid hormone (Diagnostic Products Corp, Los Angeles, CA, USA), and serum 25-hydroxyvitamin D (Immunodiagnostic Systems Inc., Fountain Hills, USA).
Assessment of dialysis adequacy and lean body mass by creatinine kinetics
Patients were asked to bring back a 24-h urine and dialysate at the same time for measurement of urea and creatinine concentration. Adequacy of dialysis was determined by measuring total weekly urea clearance (Kt/V) and creatinine clearance (CCr) using standard methods [15] . Weekly CCr was normalized to 1.73 m 2 of body surface area. Contribution of urea clearance by PD was estimated separately. Residual glomerular filtration rate (GFR) was calculated as an average of the 24-h urine urea and creatinine clearance [16] . Normalized protein catabolic rate (nPCR) was calculated by Randerson equation and normalized by actual dry weight. Lean body mass (LBM) was estimated using creatinine kinetics (CK) [17] . Peritoneal membrane transport was determined using a standard peritoneal equilibration test.
Echocardiographic examination and tissue Doppler imaging (TDI)
Two-dimensional echocardiography was performed using a GE-VingMed System 5 echocardiographic machine (GE-VingMed Sound AB, Horten, Norway) with a 3.3-mHz multiphase array probe in subjects lying in the left decubitus position by a single experienced cardiologist blinded to all clinical details of patients. All echocardiographic data were recorded according to the guidelines of the American Society of Echocardiography [18] . The ejection fraction (EF) was obtained using a modified biplane Simpson's method from apical two and four chamber views [19] . Left ventricular (LV) mass was calculated using the modified American Society of Echocardiography cube formula [20] and indexed by body surface area. We estimated the LV filling pressure non-invasively using the ratio of early transmitral flow velocity (E) to early diastolic mitral annular velocity (Em) (E/Em ratio). E and Em were estimated by pulsed wave Doppler and tissue Doppler imaging techniques as described previously [21] [22] [23] .
Follow-up and study outcome All patients were prospectively followed up for 4 years from the day of study entry or until death, kidney transplantation or permanent transfer to haemodialysis. No patient was lost to follow-up. The primary study outcome was circulatory congestion. Circulatory congestion was diagnosed by the attending physician, based on the presence of typical symptoms and signs including dyspnoea, raised jugular venous pressure and basal crepitations together with radiographic evidence of pulmonary venous congestion or interstitial oedema [1] , and resolution of symptoms, signs and radiographic changes with hypertonic PD exchanges. We included only the episodes that required hospitalization. In patients who presented to the outpatient clinic with milder symptoms including ankle oedema or facial puffiness that did not require hospitalization, the episode would not be counted as circulatory congestion. This clinical information was retrieved from the computerized Clinical Management System of the Hong Kong Hospital Authority and the Hong Kong Renal Registry which keep detailed record of all hospitalization episodes.
Statistical analysis
Continuous data were expressed as mean ± SD or median (interquartile range), depending on the distribution. Partial correlation analysis was performed to evaluate the associations of HGS with different nutritional and cardiovascular parameters, adjusting for age, gender and body height. Patients were stratified into three groups by their gender-specific tertiles of HGS at baseline. Cumulative survival curves for the three gender-specific tertiles of HGS were generated by the Kaplan-Meier method. Differences in survival among the three tertiles were compared by the log-rank test. Univariate Cox regression analysis was performed to evaluate HGS and other factors in relation to the risk of circulatory congestion at 4 years. Factors with P < 0.1 on univariate analysis were considered in the multivariable Cox regression analysis. Age, gender, duration of dialysis and nutritional parameters including serum albumin, SGA and LBM by CK were considered as important confounders for HGS and were included in the multivariable Cox regression analysis irrespective of their P-values on univariate analysis. For echocardiographic parameters, we included LV mass index (as a marker of LV hypertrophy), ejection fraction (as a marker of systolic function) and E/Em ratio (as a marker of diastolic function) in the multivariable Cox regression model. A P-value of <0.05 was considered statistically significant. Statistical analysis was performed using SPSS software, version 16.0 (SPSS, Inc., Chicago, IL, USA).
Results
The baseline characteristics of the study population are shown in Table 1 . The mean ± SD HGS of the entire study population was 17.8 ± 9.7 kg (22.4 ± 9.8 kg in men and 13.2 ± 7.2 kg in women). Nutrition status was graded to be normal in 121 patients (55.5%), mildly malnourished in 62 patients (28.4%) and moderately to severely malnourished in 35 patients (16.1%). Table 2 shows the partial correlation coefficients of HGS with nutrition and cardiac parameters, adjusting for age, gender and height. The most significant correlations (in descending order of significance) were observed between HGS and LBM by CK (P < 0.001), serum albumin (P = 0.001), LV filling pressure denoted by E/Em ratio (P = 0.001), LV mass index (P = 0.003) and background atherosclerotic vascular disease (P = 0.007).
During the 4-year follow-up, 89 patients (47 men and 42 women) were complicated with one or more episodes of circulatory congestion. Patients were stratified into three groups by the gender-specific tertiles of HGS. In men, the tertile stratification was <18 kg (lower tertile, n = 32), ≥18-27 kg (middle tertile, n = 41) and ≥27 kg (upper tertile, n = 36), and in women, the tertile stratification was <10 kg (lower tertile, n = 34), ≥10-17 kg (middle tertile, n = 37) and ≥17 kg (upper tertile, n = 38). Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers did not differ among the three tertiles (lower 27.4% vs middle 27.4% vs upper tertile 15.4%; P = 0.3). There was no significant difference in systolic blood pressure among the lower, middle and upper tertiles (147 ± 16, 147 ± 16 and 143 ± 21 mmHg, respectively, P = 0.4). A small but statistically significant difference was observed in diastolic blood pressure among the three tertiles (lower: 80 ± 10 vs middle: 84 ± 9 vs upper tertile: 8 ± 12 mmHg; P = 0.02). Erythropoietin use did not differ among the three tertiles (41.5%, 38.4% and 35.9%; P = 0.8). Serum 25-hydroxyvitamin D levels showed a significant increase across the three tertiles of increasing HGS (19.04 ± 7.80 vs 18.92 ± 6.83 vs 24.89 ± 9.67 μg/L; P < 0.001). Figure 1 shows the Kaplan-Meier estimates of a cumulative circulatory congestion event-free survival probability of the three tertiles combining men and women. The cumulative circulatory congestion event-free survival probability was significantly lower for men and women in the lower tertile (n = 66) compared to those in the middle (P = 0.016) (n = 78) or upper tertile (P = 0.001) (n = 74). Table 3 detailed the univariate Cox regression analysis of different factors in relation to the risk of circulatory congestion at 4 years. In the stepwise multivariable Cox regression analysis, LV mass index emerged as the most significant risk factor predicting circulatory congestion at 4 years (P < 0.001). HGS (P = 0.004) and LV ejection fraction (P = 0.004) were both second to LV mass index as the most significant factors predicting circulatory congestion. Serum albumin, LBM by CK and SGA failed to retain significance in the multivariable Cox regression analysis for circulatory congestion (Table 4) . Using receiver operator characteristics curve analysis with circulatory congestion at 4 years as the outcome of interest, the area under the curve was the highest for HGS (0.715), followed by LV mass index (0.706) and ejection fraction (0.631).
We stratified patients into four groups by the presence or absence of previous circulatory congestion and by ≥ or Continuous data expressed as mean ± SD unless specified otherwise.
a Median (interquartile range).
< gender-specific median of HGS (namely 12 kg in women and 22 kg in men). The cumulative circulatory congestion event-free survival probability by the Kaplan-Meier estimates is shown in Figure 2a (P < 0.001; log-rank test). Of the four groups of patients, those with previous circulatory congestion and HGS < median (n = 50) had the lowest cumulative circulatory congestion-free survival probability.
In the multivariable Cox regression analysis controlling for age, gender, duration of dialysis, background atherosclerotic vascular disease and haemoglobin, the adjusted hazard ratios in relation to circulatory congestion at 4 years were 1.54 [95% confidence interval (CI), 0.78-3.01; P = 0.21], 2.54 (95% CI, 1.31-4.93; P = 0.006) and 3.97 (95% CI, 2.10-7.49; P < 0.001) for patients with no previous circulatory congestion but HGS < median (n = 49), patients with previous circulatory congestion but HGS ≥ median (n = 35), and patients with previous circulatory congestion and HGS < median (n = 50), respectively, compared to patients with no previous circulatory congestion and HGS ≥ median (control group) (n = 84). We stratified patients into four groups by the presence or absence of systolic dysfunction (defined by LV ejection fraction < or ≥50%) and by ≥ or < gender-specific median of HGS. Figure 2b shows the cumulative circulatory congestion event-free survival probability by the KaplanMeier estimates (P < 0.001; log-rank test). Of the four groups of patients, those with EF <50% and HGS < median had the lowest cumulative circulatory congestion-free survival probability. In the multivariable Cox regression analysis adjusting for age, gender, duration of dialysis, background atherosclerotic vascular disease and haemoglobin, the adjusted hazard ratios in relation to circulatory congestion at 4 years were 1.89 (95% CI, 1.05-3.394; P = 0.034), 2.20 (95% CI, 1.13-4.28; P = 0.020) and 2.77 (95% CI, 1.46-5.28; P = 0.002) for patients with normal systolic function but HGS < median (n = 60), patients with systolic dysfunction but HGS ≥ median (n = 28), and patients with systolic dysfunction and HGS < median (n = 39), respectively, compared to patients with normal systolic function and HGS ≥ median (control group) (n = 91).
Discussion
This study is the first to demonstrate an independent significance of HGS but not other nutrition parameters including serum albumin, LBM by CK and SGA in predicting risk of circulatory congestion over a 4-year prospective follow-up in PD patients. In the multivariable Cox regression analysis, HGS was second to LV mass index as the most significant factor predicting circulatory congestion over a long-term follow-up in PD patients. Similar to other studies in chronic kidney disease [8, 9] , we observed a good correlation between HGS and LBM in PD patients, suggesting that HGS reflects body lean muscle mass. We also observed a correlation between HGS and serum albumin and SGA though not as strong. However, LBM by CK, serum albumin and SGA all failed to retain significance in predicting circulatory congestion. This suggests that HGS uniquely reflects skeletal muscle strength additional to muscle mass that is not captured by LBM by CK and 48 Fig. 1 . Cumulative circulatory congestion event-free probability of men and women stratified by their respective tertiles of handgrip strength. HGS, handgrip strength. The gender-specific tertile stratification was <18 kg in men and <10 kg in women (lower tertile, n = 66), ≥18-27 kg in men and ≥10-17 kg in women (middle tertile, n = 78) and ≥27 kg in men and ≥17 kg in women (upper tertile, n = 74). other nutritional indices, and that it is the skeletal muscle strength that predicts future risk of circulatory congestion. Loss of LBM, which mainly results from atrophy of skeletal muscle protein, is considered one of the key features in cardiac cachexia [24] . Reduced quadriceps maximal isometric strength was observed in a general population with chronic heart failure and was suggested to occur as a result of muscle atrophy and reduced muscle efficiency [25] . Several mechanisms may contribute to muscle wasting or reduced muscle strength in circulatory congestion in PD patients. Increased protein degradation was observed in different wasting conditions with upregulation of the ubiquitinproteasome proteolytic pathways demonstrated in biopsies of skeletal muscles from humans or animals [26] . Similar transcriptional changes and proteolysis were proposed to underlie muscle atrophy in cardiac cachexia. Indeed, rats with heart failure had increased ubiquitin levels [27] . Furthermore, skeletal muscle apoptosis was observed in patients with heart failure and cachexia, and was associated with an impaired exercise capacity [28, 29] . This is in keeping with our observation that poor skeletal muscle strength predisposes to further circulatory congestion. In our study, the significance of HGS in predicting future risk of circulatory congestion in PD patients was independent of, and outweighed other inflammation and nutrition markers including CRP, serum albumin, LBM by CK, SGA and normalized protein catabolic rate. In fact, CRP, LBM by CK, serum albumin, SGA and normalized protein catabolic rate showed no significant predictive value for circulatory congestion. These data suggest that HGS may more specifically reflect skeletal muscle weakness in addition to atrophy that is not captured by other nutrition parameters and that contributes to an increased future risk of circulatory congestion in PD patients.
In this study, we described novel associations between HGS and background atherosclerotic vascular disease and echocardiographic parameters including LV mass index and tissue Doppler measure E/Em ratio in PD patients. Of the different echocardiographic parameters, the strongest association was observed between HGS and E/ Em ratio. Previous studies in the general and ESRD population both suggested that E/Em ratio measured non-invasively using TDI provides a good estimate of LV filling pressure [22, 30] . More recently, E/Em ratio has been adopted by the European Society of Cardiology as part of the diagnostic criteria for diastolic heart failure [31] . We hypothesized that having an elevated E/Em ratio, reflecting an elevated LV filling pressure or impaired diastolic filling, may limit patients' exercise AVD, atherosclerotic vascular disease; hs-CRP, high-sensitivity C-reactive protein; PD, peritoneal dialysis; Kt/V, urea clearance; CrCl, creatinine clearance; GFR, glomerular filtration rate; SGA, subjective global assessment; LV, left ventricular; E/Em, ratio of early diastolic transmitral flow velocity to early diastolic mitral annular velocity; CI, confidence intervals. tolerance and physical activity, thus predisposing them to skeletal muscle atrophy and weakness, and hence its association with lower HGS. This is in keeping with a previous study showing that leg muscle volume was one of the best correlates with exercise limitation in chronic heart failure [32] . Taken together, our data suggest that HGS, which reflects skeletal muscle bulk and strength, is associated with cardiac dysfunction and predicts future risk of circulatory congestion in PD patients. In addition, it is likely that there is an important 'crosstalk' between skeletal myopathy and myocardial hypertrophy, stiffness, and dysfunction warranting further study. It remains a hypothesis to test whether exercise training that improves skeletal muscle bulk and strength may parallel an improvement in heart function and may prevent heart failure in these patients. In the stratified analysis, patients with previous circulatory congestion and lower HGS showed the highest risk of developing subsequent circulatory congestion. Among patients with or without baseline systolic dysfunction, those having higher HGS had lower risk of subsequent circulatory congestion than those with lower HGS. These data provide important evidence that skeletal muscle weakness and wasting predisposed PD patients with previous circulatory congestion or systolic dysfunction to a worse clinical outcome. Given that HGS is a simple, quick, easily performed, inexpensive and reproducible bedside test [with coefficient of variation (CV) ∼5%] and provides important information beyond other nutrition parameters, our observation suggested that HGS may be utilized clinically in conjunction with echocardiographic measures to assess the severity of cardiac dysfunction and cachexia in PD patients. On the other hand, HGS may be reflecting frailty in these patients, as suggested by a previous study to be a powerful predictor of disability, morbidity and mortality [12] . It is somewhat surprising that age was not predictive of circulatory congestion as there is usually a close relation between age and grip strength.
Our study has several limitations. Firstly, the study included prevalent PD patients which may introduce a survival bias. Secondly, the study outcome 'circulatory congestion' was diagnosed clinically by the attending physician based on the presence of typical symptoms and signs together with radiological evidence of pulmonary congestion. Only episodes that required hospitalization were included. Subclinical episodes that did not require hospitalization were not included, and therefore, the true prevalence of circulatory congestion may be underestimated in this population. In addition, the diagnosis of circulatory congestion encompassed not only the episodes Cumulative circulatory congestion event-free survival probability of men and women stratified into four groups by the presence or absence of previous circulatory congestion and ≥ or < respective median of handgrip strength (women 12 kg and men 22 kg). HGS, handgrip strength; CC, circulatory congestion. b. Cumulative circulatory congestion event-free survival probability of men and women stratified into four groups by left ventricular ejection fraction ≥50% and <50% and ≥ or < respective median of handgrip strength. HGS, handgrip strength; LV, left ventricular; EF, ejection fraction.
due to extracellular fluid overload but also those due to true cardiac dysfunction because in practical terms, it is very difficult to distinguish and separate the two entities in dialysis patients. Thirdly, HGS was measured at a single time point and did not reflect changes over time. Nevertheless, a one-off time point evaluation of HGS also reproduces the typical daily clinical situation and clearly demonstrated the potential value of performing HGS measurement to identify PD patients at increased risk of circulatory congestion. Fourthly, as the observations were mostly associative, the question whether HGS is an independent predictor of circulatory congestion or just a reflection of a worse cardiac status that in turn predicts circulatory congestion remains to be answered. Nevertheless, the predictive value of HGS appears to be higher than of LV mass index or ejection fraction. Lastly, many other unmeasured/unmentioned factors that might be mediators of this association such as carnitine status also require further elucidation. Previous data suggest a correlation between grip strength and plasma-free carnitine concentration in female but not in male haemodialysis patients [33] . There is also an anecdotal report that myocardial carnitine deficiency may contribute to chronic heart failure [34] .
In conclusion, a low HGS reflects a diseased cardiac status with cachexia and reduced skeletal muscle strength, and predicts future risk of circulatory congestion in PD patients independent of other nutritional, clinical, biochemical and echocardiographic parameters. The important link between skeletal myopathy and myocardial disease in uraemic patients warrants further investigation.
